stoxline Quote Chart Rank Option Currency Glossary
  
DSS, Inc. (DSS)
0.5415  -0.023 (-4.13%)    10-21 11:27
Open: 0.581
High: 0.581
Volume: 3,196
  
Pre. Close: 0.5648
Low: 0.5415
Market Cap: 5(M)
Technical analysis
2026-10-21 11:14:05 AM
Short term     
Mid term     
Targets 6-month :  0.8 1-year :  0.89
Resists First :  0.68 Second :  0.76
Pivot price 0.61
Supports First :  0.55 Second :  0.45
MAs MA(5) :  0.59 MA(20) :  0.63
MA(100) :  0.59 MA(250) :  0.79
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  14.7 D(3) :  10.6
RSI RSI(14): 36.6
52-week High :  1.86 Low :  0.36
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ DSS ] has closed below the lower bollinger band by 12.7%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 51.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.61 - 0.61 0.61 - 0.62
Low: 0.57 - 0.58 0.58 - 0.58
Close: 0.6 - 0.61 0.61 - 0.61
Company Description

DSS, Inc. is a globally diversified enterprise with operations across numerous industries. In product packaging, the company specializes in manufacturing and distributing custom folding cartons, mailers, photo sleeves, and advanced three-dimensional direct mail products. It also engages in the marketing and distribution of nutritional and personal care items. Within the biotechnology and biohealth sphere, DSS makes strategic investments in and acquires companies dedicated to pioneering drug discovery, prevention, and treatment methodologies for neurological, oncological, and immune-system diseases. Furthermore, it develops innovative open-air defense systems designed to combat airborne infectious agents like tuberculosis and influenza. The firm's financial services and commercial lending activities involve acquiring equity positions in undervalued commercial banks, bank holding companies, and licensed non-banking financial institutions. Its related non-banking ventures include loan syndication, mortgage banking, trust and escrow services, banking technology solutions, loan servicing, equipment leasing, problem asset management, consulting for special purpose acquisition companies (SPACs), and advisory capital raising services. For securities and investment management, DSS offers a range of services, including managing a real estate investment trust (REIT) focused on acquiring hospitals and various acute and post-acute care facilities, with an emphasis on fostering healthy living communities. The company also develops and invests in assets within the securities trading and fund management sectors, and operates as a broker-dealer for digital assets. In the alternative energy sector, DSS provides solutions such as solar farms, solar battery storage systems, and services for residential energy generation and storage. Established in 1984, the company was formerly known as Document Security Systems, Inc. before officially changing its name to DSS, Inc. in September 2021. Its headquarters are located in West Henrietta, New York.

Headline News

Tue, 13 Oct 2026
DSS Promotes Meggie Soliman to Vice President of Federal Product Operations - citybiz

Tue, 13 Oct 2026
DSS Announces Promotion of Meggie Soliman to Vice President, Federal Product Operations - EIN Presswire

Wed, 07 Oct 2026
DSS and Sightview to Showcase Eye Care Technology at AAO 2026 - The National Law Review

Thu, 24 Sep 2026
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock - Investing.com

Wed, 16 Sep 2026
DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited - Yahoo Finance

Tue, 08 Sep 2026
DSS Robotics plans a Rochester center to test AI automation at work - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Consumer Cyclical
Industry:
Packaging & Containers
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

Stoxline iOS

Alpha Bridge iOS

OptionCalc iOS

StockChart Android

Stoxline Android

Alpha Bridge Android

OptionCalc Android